Variant report

Variant	nsv5535
Chromosome Location	chr6:150339697-150361659
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:194)
CpG islands
(count:1166)
Chromatin interactive
region (count:11)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:194 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr6:150346621-150346888	GM12878	blood:	n/a	chr6:150346723-150346734 chr6:150346728-150346738 chr6:150346724-150346734
2	CEBPB	chr6:150349144-150349326	HepG2	liver:	n/a	n/a
3	CEBPB	chr6:150346556-150346899	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr6:150339733-150339933	Hela-S3	cervix:	n/a	chr6:150339786-150339797
5	CEBPB	chr6:150339700-150339896	HepG2	liver:	n/a	chr6:150339786-150339797
6	CEBPB	chr6:150353985-150354064	HepG2	liver:	n/a	n/a
7	CHD2	chr6:150346552-150346904	Hela-S3	cervix:	n/a	n/a
8	CTCF	chr6:150359537-150359747	MCF-7	breast:	n/a	n/a
9	CTCF	chr6:150359515-150359753	MCF-7	breast:	n/a	n/a
10	CTCF	chr6:150359484-150359715	A549	lung:	n/a	n/a
11	CTCF	chr6:150359514-150359748	MCF-7	breast:	n/a	n/a
12	CTCF	chr6:150359580-150359730	HEEpiC	esophagus:	n/a	n/a
13	CTCF	chr6:150359541-150359719	HepG2	liver:	n/a	n/a
14	CTCF	chr6:150359600-150359750	HMEC	breast:	n/a	n/a
15	CTCF	chr6:150359544-150359746	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr6:150359600-150359750	NHEK	skin:	n/a	n/a
17	CTCF	chr6:150359580-150359730	NHEK	skin:	n/a	n/a
18	CTCF	chr6:150359560-150359710	HRE	kidney:	n/a	n/a
19	CTCF	chr6:150351936-150351995	GM13977	blood:	n/a	n/a
20	CTCF	chr6:150359532-150359729	HUVEC	blood vessel:	n/a	n/a
21	CTCF	chr6:150359560-150359710	SAEC	small airway:	n/a	n/a
22	CTCF	chr6:150343050-150343120	GM13977	blood:	n/a	n/a
23	CTCF	chr6:150359560-150359710	HEK293	kidney:	n/a	n/a
24	CTCF	chr6:150359526-150359748	GM12878	blood:	n/a	n/a
25	CTCF	chr6:150339800-150339950	HBMEC	blood vessel:	n/a	n/a
26	CTCF	chr6:150350200-150350350	GM12866	blood:	n/a	n/a
27	CTCF	chr6:150359513-150359751	Gliobla	brain:	n/a	n/a
28	CTCF	chr6:150359506-150359763	NHEK	skin:	n/a	n/a
29	CTCF	chr6:150359526-150359711	GM12892	blood:	n/a	n/a
30	CTCF	chr6:150345270-150345328	LNCaP	prostate:	n/a	n/a
31	CTCF	chr6:150359574-150359739	Hela-S3	cervix:	n/a	n/a
32	CTCF	chr6:150345677-150345737	Spleen_OC	spleen:	n/a	n/a
33	CTCF	chr6:150347740-150347890	HEK293	kidney:	n/a	n/a
34	CTCF	chr6:150344908-150344980	Kidney_OC	kidney:	n/a	n/a
35	CTCF	chr6:150359524-150359750	A549	lung:	n/a	n/a
36	CTCF	chr6:150341183-150341290	GM13976	blood:	n/a	n/a
37	CTCF	chr6:150347680-150347830	HRE	kidney:	n/a	n/a
38	CTCF	chr6:150359566-150359568	GM19240	blood:	n/a	n/a
39	CTCF	chr6:150344108-150344152	GM20000	blood:	n/a	n/a
40	CTCF	chr6:150359508-150359813	K562	blood:	n/a	n/a
41	CTCF	chr6:150359521-150359738	MCF-7	breast:	n/a	n/a
42	CTCF	chr6:150359509-150359772	K562	blood:	n/a	n/a
43	CTCF	chr6:150359571-150359716	GM19240	blood:	n/a	n/a
44	CTCF	chr6:150359560-150359710	HEEpiC	esophagus:	n/a	n/a
45	CTCF	chr6:150341440-150341590	HBMEC	blood vessel:	n/a	n/a
46	CTCF	chr6:150341400-150341550	HEK293	kidney:	n/a	n/a
47	CTCF	chr6:150359560-150359710	AG04449	skin:	n/a	n/a
48	CTCF	chr6:150359580-150359730	SAEC	small airway:	n/a	n/a
49	CTCF	chr6:150359587-150359677	Pancreas_OC	pancreas:	n/a	n/a
50	CTCF	chr6:150359529-150359665	A549	lung:	n/a	n/a

(count:1166 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:150346921-150346971	HPAEpiC	pulmonary alveolar:	n/a
2	chr6:150346863-150346913	NT2-D1	testis:	n/a
3	chr6:150346921-150346971	HL-60	blood:	n/a
4	chr6:150356698-150356748	SKMC	muscle:	n/a
5	chr6:150359130-150359180	T-47D	breast:	n/a
6	chr6:150346497-150346547	AG10803	skin:	n/a
7	chr6:150346497-150346547	HUVEC	blood vessel:	n/a
8	chr6:150346921-150346971	HPAEpiC	pulmonary alveolar:	n/a
9	chr6:150346863-150346913	NT2-D1	testis:	n/a
10	chr6:150346921-150346971	HL-60	blood:	n/a
11	chr6:150356698-150356748	SKMC	muscle:	n/a
12	chr6:150359130-150359180	T-47D	breast:	n/a
13	chr6:150346497-150346547	AG10803	skin:	n/a
14	chr6:150346497-150346547	HUVEC	blood vessel:	n/a
15	chr6:150351274-150351324	GM06990	blood:	n/a
16	chr6:150357289-150357339	GM12892	blood:	n/a
17	chr6:150346800-150346850	AG04450	lung:	fetal
18	chr6:150359383-150359433	HEK293	kidney:	embryo
19	chr6:150346921-150346971	BE2_C	brain:	n/a
20	chr6:150346816-150346866	NH-A	brain:	n/a
21	chr6:150346816-150346866	MCF10A-Er-Src	breast:	n/a
22	chr6:150346921-150346971	NT2-D1	testis:	n/a
23	chr6:150359130-150359180	PrEC	prostate:	n/a
24	chr6:150360829-150360879	HepG2	liver:	n/a
25	chr6:150359383-150359433	BE2_C	brain:	n/a
26	chr6:150346800-150346850	SK-N-SH	brain:	n/a
27	chr6:150346787-150346837	PANC-1	pancreas:	n/a
28	chr6:150346497-150346547	SK-N-SH	brain:	n/a
29	chr6:150346800-150346850	HepG2	liver:	n/a
30	chr6:150346497-150346547	Jurkat	blood:	n/a
31	chr6:150359383-150359433	U87	brain:	n/a
32	chr6:150358873-150358923	NHBE	bronchial:	n/a
33	chr6:150346800-150346850	NB4	blood:	n/a
34	chr6:150356698-150356748	K562	blood:	n/a
35	chr6:150346497-150346547	GM12891	blood:	n/a
36	chr6:150346800-150346850	NH-A	brain:	n/a
37	chr6:150356698-150356748	HRE	kidney:	n/a
38	chr6:150346497-150346547	NH-A	brain:	n/a
39	chr6:150357289-150357339	PFSK-1	brain:	n/a
40	chr6:150360829-150360879	HCM	heart:	n/a
41	chr6:150346787-150346837	HAEpiC	amniotic membrane:	n/a
42	chr6:150346921-150346971	GM12892	blood:	n/a
43	chr6:150358873-150358923	AG09319	gingival:	n/a
44	chr6:150346858-150346908	HEK293	kidney:	embryo
45	chr6:150346721-150346771	PrEC	prostate:	n/a
46	chr6:150359383-150359433	AG04449	skin:	fetal
47	chr6:150347012-150347062	Caco-2	colon:	n/a
48	chr6:150359383-150359433	HUVEC	blood vessel:	n/a
49	chr6:150346921-150346971	A549	lung:	n/a
50	chr6:150346921-150346971	BJ	skin:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:150354901..150357527-chr6:150362159..150364156,2	MCF-7	breast:
2	chr6:150351052..150353254-chr6:150355645..150357982,2	K562	blood:
3	chr6:150261749..150263311-chr6:150348518..150350047,2	MCF-7	breast:
4	chr6:150323301..150326870-chr6:150337464..150339739,3	MCF-7	breast:
5	chr6:150155381..150157771-chr6:150346025..150347800,2	MCF-7	breast:
6	chr6:150354931..150357925-chr6:150386556..150388661,2	K562	blood:
7	chr6:150351052..150353254-chr6:150355645..150357982,2	K562	blood:
8	chr6:150350371..150352271-chr6:150387708..150390265,2	MCF-7	breast:
9	chr6:150258514..150260378-chr6:150337573..150339969,2	MCF-7	breast:
10	chr6:150355810..150358323-chr6:150360175..150362251,2	K562	blood:
11	chr6:150355810..150358323-chr6:150360175..150362251,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ULBP1-2	chr6:150354375-150354702	NONHSAT115530
2	lnc-ULBP1-2	chr6:150353905-150354172	NONHSAT115530

No data

Variant related genes	Relation type
PHBP1	TF binding region
RAET1L	TF binding region
RAET1M	TF binding region
PHBP1	CpG island
RAET1L	CpG island
RAET1M	CpG island
ENSG00000213091	chromatin interactions
ENSG00000120256	chromatin interactions
ENSG00000131015	chromatin interactions
ENSG00000131019	chromatin interactions
ENSG00000235972	chromatin interactions
ENSG00000218358	chromatin interactions

Extended variants
information (count: 1059 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:1059 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576933584	chr6:150339729-150339730	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs150356268	chr6:150339779-150339780	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs560859882	chr6:150339799-150339800	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs556673498	chr6:150339807-150339808	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs529793958	chr6:150339859-150339860	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs188255266	chr6:150339870-150339871	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs549971321	chr6:150339877-150339878	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs369919143	chr6:150339915-150339916	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs545859054	chr6:150339939-150339940	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs138004858	chr6:150339942-150339943	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs377417049	chr6:150339955-150339956	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs571605706	chr6:150339957-150339958	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs534192744	chr6:150339958-150339959	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs554458742	chr6:150339969-150339970	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs574405945	chr6:150340002-150340003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs536806798	chr6:150340005-150340006	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs6913561	chr6:150340035-150340036	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs376135732	chr6:150340049-150340050	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs181135299	chr6:150340075-150340076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs370556772	chr6:150340087-150340088	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs545088097	chr6:150340102-150340103	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs564873663	chr6:150340115-150340116	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs185054600	chr6:150340130-150340131	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs540628870	chr6:150340131-150340132	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs560822732	chr6:150340148-150340149	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs148801810	chr6:150340162-150340163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs112730414	chr6:150340180-150340181	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs367629230	chr6:150340195-150340196	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543386635	chr6:150340223-150340224	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs563494562	chr6:150340226-150340227	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs142441566	chr6:150340228-150340229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs115701203	chr6:150340252-150340253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs189984730	chr6:150340255-150340256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs181620867	chr6:150340256-150340257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs550006110	chr6:150340277-150340278	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs528003147	chr6:150340306-150340307	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs563434342	chr6:150340326-150340327	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs547826058	chr6:150340359-150340360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs567695719	chr6:150340368-150340369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs536921761	chr6:150340378-150340379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs556634608	chr6:150340393-150340394	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs202089145	chr6:150340418-150340419	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs570224022	chr6:150340465-150340466	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs116203892	chr6:150340507-150340508	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs9478362	chr6:150340526-150340527	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs571831450	chr6:150340527-150340528	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs540591402	chr6:150340545-150340546	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs554128768	chr6:150340572-150340573	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs34708472	chr6:150340584-150340585	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs574122979	chr6:150340586-150340587	Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:492 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150335200-150340400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr6:150336800-150339800	Weak transcription	HMEC	breast
3	chr6:150339800-150340000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr6:150339800-150340600	Enhancers	HMEC	breast
5	chr6:150340200-150340400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr6:150340200-150340600	Enhancers	Esophagus	oesophagus
7	chr6:150340400-150340600	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr6:150340400-150340600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr6:150340400-150340600	Bivalent Enhancer	Placenta	Placenta
10	chr6:150340400-150340600	Enhancers	NHEK	skin
11	chr6:150340400-150340800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr6:150340400-150340800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr6:150340600-150341600	Weak transcription	Esophagus	oesophagus
14	chr6:150340600-150345800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr6:150340600-150345800	Weak transcription	HMEC	breast
16	chr6:150340600-150346000	Weak transcription	NHEK	skin
17	chr6:150340800-150346000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr6:150340800-150346000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr6:150341600-150342200	Enhancers	Esophagus	oesophagus
20	chr6:150342200-150345200	Weak transcription	Esophagus	oesophagus
21	chr6:150345200-150345800	Enhancers	Esophagus	oesophagus
22	chr6:150345800-150346000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr6:150345800-150346200	Enhancers	HMEC	breast
24	chr6:150345800-150346400	Enhancers	Hela-S3	cervix
25	chr6:150345800-150346600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr6:150345800-150346800	Enhancers	Lung	lung
27	chr6:150345800-150347000	Enhancers	Gastric	stomach
28	chr6:150345800-150347000	Bivalent Enhancer	Stomach Mucosa	stomach
29	chr6:150345800-150347200	Flanking Active TSS	Esophagus	oesophagus
30	chr6:150345800-150347400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
31	chr6:150346000-150346200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
32	chr6:150346000-150346200	Enhancers	NHEK	skin
33	chr6:150346000-150346400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr6:150346000-150346400	Bivalent Enhancer	Colonic Mucosa	Colon
35	chr6:150346000-150346400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
36	chr6:150346000-150346600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
37	chr6:150346000-150346800	Bivalent Enhancer	Fetal Stomach	stomach
38	chr6:150346000-150347000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr6:150346000-150347400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr6:150346000-150348200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr6:150346200-150346400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr6:150346200-150346400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr6:150346200-150346400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
44	chr6:150346200-150346400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr6:150346200-150346400	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
46	chr6:150346200-150346400	Bivalent Enhancer	Adipose Nuclei	Adipose
47	chr6:150346200-150346400	Bivalent Enhancer	Brain Hippocampus Middle	brain
48	chr6:150346200-150346400	Flanking Bivalent TSS/Enh	Colon Smooth Muscle	Colon
49	chr6:150346200-150346400	Bivalent Enhancer	Fetal Thymus	thymus
50	chr6:150346200-150346400	Bivalent Enhancer	Right Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links